Senexin A is primarily utilized in research focused on aging and cellular senescence. It is known for its ability to selectively eliminate senescent cells, which are cells that have stopped dividing and contribute to aging and various age-related diseases. By targeting these cells, Senexin A holds potential in developing therapies for conditions such as fibrosis, osteoarthritis, and other degenerative diseases. Its application in preclinical studies has shown promise in improving tissue function and extending healthspan, making it a significant compound in the field of gerontology and regenerative medicine.